Protagonist Therapeutics, Inc Deferred Income Tax Assets, Net
Protagonist Therapeutics, Inc (PTGX) had Deferred Income Tax Assets, Net of $1.08 million as of 2020-03-31, per its 10-Q filed 2020-05-07.
Discontinued › Balance Sheet › Assets
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2021-03-10
- 2020-03-31: Deferred Income Tax Assets, Net $1.08M.
- 2019-12-31: Deferred Income Tax Assets, Net $1.43M.
- 2019-09-30: Deferred Income Tax Assets, Net $2.13M.
- 2019-06-30: Deferred Income Tax Assets, Net $2.10M.
| Period end | Deferred Income Tax Assets, Net |
|---|---|
| 2020-03-31 | $1.08M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $1.43M 10-K · filed 2021-03-10 |
| 2019-09-30 | $2.13M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $2.10M 10-Q · filed 2019-08-07 |
| 2018-12-31 | $658.00K 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |